Roivant Sciences (ROIV) Cash from Investing Activities (2020 - 2026)

Roivant Sciences (ROIV) has reported Cash from Investing Activities for 7 consecutive years, with $281.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Investing Activities rose 125.91% year-over-year to $281.3 million; the trailing twelve-month figure through Jun 2026 stood at -$1.5 billion (up 78.67% YoY), and the FY2026 full-year result was -$682.3 million, up 61.37% from the prior year.
• Cash from Investing Activities rose to $281.3 million in Q2 2026 per ROIV's latest filing, from -$855.8 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $5.2 billion in Q4 2023 and bottomed at -$3.3 billion in Q3 2024.
• Historically, Cash from Investing Activities has averaged -$217.4 million across 5 years, with a median of -$36.5 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities jumped 3392.76% in 2023, then plunged 112409.43% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$157.8 million in 2022, then surged by 3392.76% to $5.2 billion in 2023, then slumped by 154.66% to -$2.8 billion in 2024, then surged by 69.87% to -$855.8 million in 2025, then surged by 132.86% to $281.3 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $281.3 million, -$855.8 million, and $120.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.